Cigna Corp (CI · NYSE)

CI · MARKET VIEW

Market view · as of Jun 22, 2026

Revenue (TTM)
$277.89B
+4.6% YoY
Gross margin
9.1%
EPS (latest q)
$7.79
vs $7.61 est · beat
52-wk position
44.8%
-14.7% vs 52w high · -0.8% 1mo

Price (last ~year)

Cigna Corp (CI) has exceeded analyst earnings estimates for four consecutive quarters, posting a 29.1% year-over-year earnings increase alongside $277.89B in trailing twelve-month revenue. As of March 31, 2026, the $73.88B market cap company maintained $30.90B in total debt with a 2.3x debt-to-EBITDA ratio. Shares recently closed at $279.27, down 5.3% over the last five days, amid a pending network contract deadline with Baptist Health.

Valuation

Market cap
$73.88B
P/E
11.18
PEG
0.836
P/B
1.75
P/S
0.266
EV/EBITDA
7.68
Beta
0.302
Analyst target
$340.5

Quality & returns

Gross margin
9.1%
Operating margin
5.5%
Profit margin
2.3%
ROE
16.3%
ROA
4.8%

Price movement

Last
$279.27
1-month
-0.8%
3-month
+5.6%
RSI (14)
53
vs SMA200
+0.3%
52-wk position
44.8% -14.7% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$68.49B$2.36B$1.65B$3.28B
2025-12-31$72.47B$2.15B$1.23B$2.54B
2025-09-30$69.75B$2.58B$1.87B$3.34B
2025-06-30$67.23B$2.43B$1.53B$3.04B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots